Morning Session

08:30 – 09:00

Registration

09:00 – 09:15

Morning Session Moderator

Mr. Wang Maochun, Vice President, CCCMHPIE

Opening Remark           

Mr. Zhou Hui, President, CCCMHPIE

Informa Markets

09:15 – 10:25

Keynote Speech

09:15–09:45   

Speaker: Chinese Pharmaceutical Association (CPA)

Topic: Analysis of  China’s Drug R&D Policy Environment in Recent Years

09:45–10:25

Speaker£ºDr Trajko Spasenovski, Life Sciences Consultant- APAC and Emerging Markets, Clarivate Analytics

Topic: Global Innovation Trends in Pharmaceutical Industry

10:25 – 10:40

²èЪ Tea Break

10:40 – 11:40

10:40–11:40

Panel Discussion 1£ºLong-term International Development Strategies of China’s  Healthcare  Companies.

Moderator: Madam. Meng Dongping, Vice President, CCCMHPIE

Panellists:

Mr. Wu Yifang, President and CEO, FOSUN PHARMA

Mr. Chang Liang, President, Aland Group

Mr. Shen Yaping, Vice President, Heng Rui Medicine

Mindray Medical

SINOPHARM

11:40 – 12:00

Launch Ceremony

Top 100 Internationalized Pharmaceutical Companies in 2019

——Quality Suppliers and Partners in the World Market (Top 60)

——World Leading Companies for Preparations (Top 20)

——the Most Potential Companies (Top 20)

12:00 – 13:30

Lunch

Afternoon Session

13:30 – 14:50

Afternoon Session Moderator

Mr. Tan Shengcai, Vice President, CCCMHPIE

Keynote Speech

13:30 – 14:10

Speaker: Academician of Chinese Academy of Sciences

Topic: The Latest R&D Progress of Pharmaceutical innovation and China's Opportunities

14:10 – 14:50

Speaker:

 Mr. Lin Jianning, Director, NMPA Southern Medicine Economic Research Institute

Topic: Analysis of the Development of China’s Pharmaceutical Industry in 2019

14:50 - 15:10

Prize of Special Contribution for CCCMHPIE’s 30th Anniversary

15:10 – 17:10

15:10 – 16:10

Panel Discussion 2£ºNew Trends of China-Foreign Pharmaceutical Industry Cooperation

Moderator: Representative from Financial Institutions

Panellists:  

Mr. Xia Mingde, Senior Director, Asia Pacific Innovation Center, Johnson & Johnson

Mr. Yin Jinqun, Vice President and COO, Kang Hong Pharmaceutical

Mr. Chen Bingyu, Partner, Hollyhigh International Capital

Humanwell Healthcare

3S Pharmaceutical Group

16:10 – 17:10

Panel Discussion 3£ºPath towards Green Development of Pharmaceutical Industry in the New Era

Moderator: Madam. Xue Yan, Vice President, Intertek China Life & Environment Science

Panellists:

Mr. Xiao Yi, Senior Vice President, Asymchem,

Mr. Gu Haoliang, Vice President of Shanghai Pharmaceutical Group,

Mr. Jonathan Wang, Vice President, Zai Lab,

MERCK China,

North China Pharmaceutical